122 related articles for article (PubMed ID: 34987219)
1. Author Correction: Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice.
Wang L; Aschenbrenner D; Zeng Z; Cao X; Mayr D; Mehta M; Capitani M; Warner N; Pan J; Wang L; Li Q; Zuo T; Cohen-Kedar S; Lu J; Ardy RC; Mulder DJ; Dissanayake D; Peng K; Huang Z; Li X; Wang Y; Wang X; Li S; Bullers S; Gammage AN; Warnatz K; Schiefer AI; Krivan G; Goda V; Kahr WHA; Lemaire M; ; Lu CY; Siddiqui I; Surette MG; Kotlarz D; Engelhardt KR; Griffin HR; Rottapel R; Decaluwe H; Laxer RM; Proietti M; Hambleton S; Elcombe S; Guo CH; Grimbacher B; Dotan I; Ng SC; Freeman SA; Snapper SB; Klein C; Boztug K; Huang Y; Li D; Uhlig HH; Muise AM
Nat Genet; 2022 Feb; 54(2):213. PubMed ID: 34987219
[No Abstract] [Full Text] [Related]
2. Syk inhibitor attenuates inflammation in lupus mice from FcgRIIb deficiency but not in pristane induction: the influence of lupus pathogenesis on the therapeutic effect.
Issara-Amphorn J; Somboonna N; Pisitkun P; Hirankarn N; Leelahavanichkul A
Lupus; 2020 Sep; 29(10):1248-1262. PubMed ID: 32700597
[TBL] [Abstract][Full Text] [Related]
3. Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model.
Yoshimoto T; Hayashi T; Kondo T; Kittaka M; Reichenberger EJ; Ueki Y
J Bone Miner Res; 2018 Aug; 33(8):1513-1519. PubMed ID: 29669173
[TBL] [Abstract][Full Text] [Related]
4. Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2-induced airway inflammation and remodeling.
Tabeling C; Herbert J; Hocke AC; Lamb DJ; Wollin SL; Erb KJ; Boiarina E; Movassagh H; Scheffel J; Doehn JM; Hippenstiel S; Maurer M; Gounni AS; Kuebler WM; Suttorp N; Witzenrath M
Allergy; 2017 Jul; 72(7):1061-1072. PubMed ID: 27906453
[TBL] [Abstract][Full Text] [Related]
5. Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation.
Matsubara S; Koya T; Takeda K; Joetham A; Miyahara N; Pine P; Masuda ES; Swasey CH; Gelfand EW
Am J Respir Cell Mol Biol; 2006 Apr; 34(4):426-33. PubMed ID: 16339999
[TBL] [Abstract][Full Text] [Related]
6. Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases.
Biagioli M; Mencarelli A; Carino A; Cipriani S; Marchianò S; Fiorucci C; Donini A; Graziosi L; Baldelli F; Distrutti E; Costantino G; Fiorucci S
Inflamm Bowel Dis; 2017 Dec; 24(1):123-135. PubMed ID: 29272492
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease.
Bukong TN; Iracheta-Vellve A; Saha B; Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Catalano D; Kodys K; Szabo G
Hepatology; 2016 Oct; 64(4):1057-71. PubMed ID: 27302565
[TBL] [Abstract][Full Text] [Related]
8. Functional roles of Syk in macrophage-mediated inflammatory responses.
Yi YS; Son YJ; Ryou C; Sung GH; Kim JH; Cho JY
Mediators Inflamm; 2014; 2014():270302. PubMed ID: 25045209
[TBL] [Abstract][Full Text] [Related]
9. Signaling through Syk or CARD9 Mediates Species-Specific Anti-
Zajta E; Csonka K; Tóth A; Tiszlavicz L; Németh T; Orosz A; Novák Á; Csikós M; Vágvölgyi C; Mócsai A; Gácser A
mBio; 2021 Aug; 12(4):e0160821. PubMed ID: 34465030
[TBL] [Abstract][Full Text] [Related]
10. Syk negatively regulates TLR4-mediated IFNβ and IL-10 production and promotes inflammatory responses in dendritic cells.
Yin H; Zhou H; Kang Y; Zhang X; Duan X; Alnabhan R; Liang S; Scott DA; Lamont RJ; Shang J; Wang H
Biochim Biophys Acta; 2016 Mar; 1860(3):588-98. PubMed ID: 26708990
[TBL] [Abstract][Full Text] [Related]
11. Myeloid cell-mediated renal injury in rapidly progressive glomerulonephritis depends upon spleen tyrosine kinase.
Ryan J; Ma FY; Han Y; Ozols E; Kanellis J; Tesch GH; Nikolic-Paterson DJ
J Pathol; 2016 Jan; 238(1):10-20. PubMed ID: 26251216
[TBL] [Abstract][Full Text] [Related]
12. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.
Braselmann S; Taylor V; Zhao H; Wang S; Sylvain C; Baluom M; Qu K; Herlaar E; Lau A; Young C; Wong BR; Lovell S; Sun T; Park G; Argade A; Jurcevic S; Pine P; Singh R; Grossbard EB; Payan DG; Masuda ES
J Pharmacol Exp Ther; 2006 Dec; 319(3):998-1008. PubMed ID: 16946104
[TBL] [Abstract][Full Text] [Related]
13. Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity.
Martínez-López M; Iborra S; Conde-Garrosa R; Mastrangelo A; Danne C; Mann ER; Reid DM; Gaboriau-Routhiau V; Chaparro M; Lorenzo MP; Minnerup L; Saz-Leal P; Slack E; Kemp B; Gisbert JP; Dzionek A; Robinson MJ; Rupérez FJ; Cerf-Bensussan N; Brown GD; Bernardo D; LeibundGut-Landmann S; Sancho D
Immunity; 2019 Feb; 50(2):446-461.e9. PubMed ID: 30709742
[TBL] [Abstract][Full Text] [Related]
14. Syk Inhibitor Attenuates Polymicrobial Sepsis in FcgRIIb-Deficient Lupus Mouse Model, the Impact of Lupus Characteristics in Sepsis.
Issara-Amphorn J; Chancharoenthana W; Visitchanakun P; Leelahavanichkul A
J Innate Immun; 2020; 12(6):461-479. PubMed ID: 32927460
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.
Coffey G; DeGuzman F; Inagaki M; Pak Y; Delaney SM; Ives D; Betz A; Jia ZJ; Pandey A; Baker D; Hollenbach SJ; Phillips DR; Sinha U
J Pharmacol Exp Ther; 2012 Feb; 340(2):350-9. PubMed ID: 22040680
[TBL] [Abstract][Full Text] [Related]
16. Syk Regulates Neutrophilic Airway Hyper-Responsiveness in a Chronic Mouse Model of Allergic Airways Inflammation.
Salehi S; Wang X; Juvet S; Scott JA; Chow CW
PLoS One; 2017; 12(1):e0163614. PubMed ID: 28107345
[TBL] [Abstract][Full Text] [Related]
17. The Syk Tyrosine Kinase Is Required for Skin Inflammation in an In Vivo Mouse Model of Epidermolysis Bullosa Acquisita.
Németh T; Virtic O; Sitaru C; Mócsai A
J Invest Dermatol; 2017 Oct; 137(10):2131-2139. PubMed ID: 28576735
[TBL] [Abstract][Full Text] [Related]
18. [Involvement of Syk in pathology of systemic autoimmune disease].
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Saito K; Akashi K; Tanaka Y
Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):56-61. PubMed ID: 22374444
[TBL] [Abstract][Full Text] [Related]
19. Targeting Syk in Autoimmune Rheumatic Diseases.
Deng GM; Kyttaris VC; Tsokos GC
Front Immunol; 2016; 7():78. PubMed ID: 27014261
[TBL] [Abstract][Full Text] [Related]
20. Syk-MyD88 Axis Is a Critical Determinant of Inflammatory-Response in Activated Macrophages.
Yi YS; Kim HG; Kim JH; Yang WS; Kim E; Jeong D; Park JG; Aziz N; Kim S; Parameswaran N; Cho JY
Front Immunol; 2021; 12():767366. PubMed ID: 35003083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
